About
Zynerba Pharmaceuticals develops and commercializes synthetic cannabinoid therapeutics targeting rare and near-rare neuropsychiatric disorders.
Explore Zynerba Pharmaceuticals's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.